RELIANCE BIOSCIENCES delivers molecular diagnostics via exosomes for diagnostic and assessment of neurodegenerative diseases and unmet clinical needs.
Exosomes are nanoparticles secreted from disease-specific cells and provide personalized and actionable disease insights. Our proprietary immunoassay technology enables high sensitivity exosomal protein detection using blood.
OUR CURRENT FOCUS
Early detection of Alzheimer’s since it can be detected up to 15-20 years before the disease onset
OUR CURRENT FOCUS
Early detection of Alzheimer’s since it can be detected up to 15-20 years before the disease onset
Fully executed agreement with an Australian Alzheimer organization with 8,500 contact-patient-year samples available for fast-track study on AD, with PET scan data as control.
5. MTA executed
MTA fully executed with Harvard Med School/MGH with 500 samples for early assessment of lung cancer.
6. NDA executed
Multiple NDAs fully executed with pharmas and organizations towards clinical development.